The centrifugal fast analyzer was introduced by Anderson (1) ; it has since been used to examine many enzymatic and nonenzymatic methods. We have adapted the assay for alkaline phosphatase (AP;3 orthophosphoric monoester phosphohydrolase, EC 3.1.3.1) of Hausamen et al. (2) for use with a prototype-model centrifugal analyzer. Alkaline phosphatase assays are of clinical importance because increased activity in serum may indicate osteoblastic activity, hepatobiliary disease, pregnancy, or the presence of a tumor (3) . The tissue origin of isoenzymes of serum AP can be separated into three main groups: (a) bone, (b) liver, and (c) isoenzymes sensitive to L-phenylalanine. The third group consists of isoenzymes from intestine, placenta, and neoplastic tissue, for which tissue origin is usually suggested by the patient's case history. Differentiation between bone and liver isoenzyme is not so readily made. It is often very difficult to make a clinical laboratory assessment of the probable tissue source. Besides the various electrophoretic techniques (4) that have been used to separate bone and liver isoenzymes, inactivation of different isoenzymes by heat (5) and urea (6) has been used in differentiating the tissue source.
In the method that we propose, urea is used to differentiate bone and liver alkaline phosphatase. The centrifugal analyzer has enabled us to gain the precision necessary to resolve the overlap that has been present in earlier studies in which urea was used as a selective inhibitor of bone alkaline phosphatase (6). 
Materials and Methods Apparatus
UN-EAR KINETIC ENZYME RATE ANALYSIS, and (3) CURSOR ENZYME RATE ANALYSIS; the latter program allows the study of activity between cursors that are set and selected by the user. These programs, written originally at the Oak Ridge National Laboratory (personal communication, C. Burtis), were modified by us and are available upon request.
Sera and reagents were dispensed by using the direct digital-control pipet described previously by Nishi (7 The three major isoenzymes-liver, bone, and intestine-were used as controls to ascertain their relative activities in the presence of the inhibitors. Liver tissue homogenates were prepared from postmortem specimens from a patient who had died of nonhepatic disease, intestinal isoenzymes from jejunal biopsy of normal volunteers at the -National Institutes of Health, and bone isoenzymes from the sera of three patients, each of whom had an increase of more than 20-fold in alkaline phosphatase activity secondary to marked osteoblastic activity caused by secondary hyperparathyroidism, Paget's disease of bone, or osteitis deformans.
Procedures
The centrifugal analyzer was calibrated daily with DEA buffer dispensed into each of the cuvets. Whenever the transmittance in any of the cuvets differed from that of the reference blank by more than 2%, the analyzer would be washed and calibrated again. Before each day's run the factor relating the absorbance at 405 nm to concentration of p-nitrophenol (Sigma Chemical Co.) was determined.
Known dilutions of p-nitrophenol standards in DEA buffer were pipetted in the same manner as the serum samples and then read at 405 nm. The factor thus determined was used in subsequent calculations of the activity of the sera.
The first group of determinations consisted only of "total" AP activity of pooled serum; the second group of determinations included the triad of total AP, L-phenylalanine-insensitive AP, and urea-insensitive AP, all of which were determined on selected patients as well as on a selected group of normal volunteers.
Sera of patients at the NIH, pooled normal sera, and sera from a group of 91 normal volunteers were either assayed on the day of collection or stored at -20#{176}C and assayed within two weeks.
When only total AP was determined, 20 l of sample serum was diluted with DEA buffer to a total of 150 l and dispensed into well A (innermost well) of the transfer disk, and 450 zl of 21.5 millimolar p-nitrophenylphosphate substrate in DEA buffer was pipetted into well B (middle well). Cuvet No. 1 was the reference blank and was treated like the others except that 20 tl of DEA buffer rather than of serum was added to the mixture. During all analytical runs the temperature was controlled at 30#{176}C; the wavelength was set at 405 nm with an effective band pass of 1 nm; and preincubation time (time for mixing of the solutions in the cuvet until the first absorbance reading) was. 30 s. The total run time was 150 s, with absorbance readings recorded every 15 s; each recorded value was the average of eight consecutive absorbance readings, all made within a period of 1 s. The activity was computed by using the LINEAR KINETIC ENZYME RATE ANALYSIS program.
For AP isoenzyme determinations, 10 l of serum sample was pipetted into well A and diluted to 150 d with DEA buffer. Cuvet No. 1 was the reference blank, and two of the cuvets were used for the control pooled sera; the remaining 12 cuvets were reserved for four patient AP determinations.
Three adjacent cuvets having either (a) no inhibitor present, however, the length of the run for the AP isoenzymes differed from that of the total AP assay system: preincubation time was 100 s, followed by a recorded interval of 300 s. If absorbance changed .by more than 1.2 absorbance units, the serum sample was diluted appropriately and re-analyzed. The activity of the total AP (without inhibitors present) and the L-phenylalanine-insensitive AP activity were determined during the 300 s by using the LINEAR KINETIC ENZYME RATE ANALYSIS program. For the urea-insensitive AP activity we used a longer preincubation period of 340 s, including the first 100-s preincubation common to all the three assays; the activity was determined for 60 s by using the CUR-SOR ENZYME RATE ANALYSIS program
Results

Photometric Linearity
The photometric linearity of the procedure was examined by measuring the absorbance at 405 nm of the product of the AP reaction, p-nitrophenol, at various concentrations.
The p-nitrophenol solutions were diluted from a concentrated standard. Precision Table 1 summarizes the precision of our AP assays. The intradisk precision-the coefficient of variations for 14 serum samples determined in the same run at 30#{176}C-averaged 0.48%. One coefficient of variation between runs was analyzed in two ways: (a) the result for one cuvet (pooled sera) in each disk was compared with the same cuvet (pooled sera) in other runs made during the same hour; and (b) the same, except results were taken for the same cuvet (pooled sera) over a period of many days and at different times during the day. In Table 1 we demonstrate that one coefficient of variation for within-day, interdisk runs averaged 0.63%; however, the daytoday coefficient of variation was much greater. The reasons for this difference will be presented under "Discussion". Table 2 gives data illustrating that three factors are important in improving the precision of the analyzer: (a) increasing the number of absorbance readings during the run; (b) increasing the time duration of the run; and (c) increasing the activity of the sample itself. Our results confirm the theoretical and practical considerations of centrifugal analyzers suggested by Maclin (8). As noted in Table 2 , the precision of the intradisk runs improves significantly until it levels off at about a 0.5% coefficient of variation. 450 l (substrate buffer volume) ( Table 3 ). The great precision of our pipetting system can be best appreciated when the results of intradisk runs on the same serum samples are compared with those obtained using manual fluid-dispensing techniques.
In Table  3 , we contrast the single coefficient of variation of 0.48% found when the direct digital pipet of Nishi was used with that of 1.23% when the Eppendorf pipet (same tip) was used, and with 1.85% when different tips were used to pipet the critical 20-z1 volume of serum.
Using the calculated expected error due to pipetting of 0.34% and the intradisk coefficient of variation of 0.48%, we can determine the instrument error In our laboratory, the present routine procedure used for AP assay is based on the method of Morgenstern et al. (10) , who used an AutoAnalyzer I (Technicon) end-point determination at 37#{176}C. We compared results for sera analyzed by the end-point method and by the kinetic procedure (Figure 2 ). The correlation coefficient indicates the good agreement between results of the two methods.
AP lsoenzyme Determinations
We determined the effects of L-phenylalanlne and urea on the activity of organ-specific AP isoenzymes. The degree of inhibition with L-phenylalanine depended on the concentration of the inhibitor but was independent of the total time of incubation with the inhibitor. Residual AP activity with urea was related to both the concentration of urea and length of incubation time. As noted in Table 4 , L-phenylalanine inhibited intestinal AP much more strongly than it did the bone and liver isoenzymes. We elected to use 10 millimoles of L-phenylalanine per liter, because that concentration best differentiated intestinal isoenzyme from other isoenzymes.
To achieve the maximun difference in degree of inhibition of bone and liver isoenzymes by urea, we preincubated for about 6 mm (at 30#{176}C) with 3.3-molar urea. Repeated duplicate analyses of the percentage AP activity remaining after L-phenylalanine and urea incubation with different sources of the same isoenzyme gave very consistent results. The concentration of either inhibitor and the selected time interval in the case of urea-insensitive AP were the critical factors to keep constant. caused by the electronic-optical uncertainty.
In the case of intradisk precision, the total variation is due only to electronic-optical uncertainty and to imprecision in fluid dispensing because the effects of temperature and sample handling can be dismissed. At 30#{176}C, with a change in absorbance of 0.06 units/ minute for a total run of 150 s, the calculated electronic-optical uncertainty equals 0.34%, coincidentally the same value as the coefficient of variation owing to fluid dispensing. The value of the electronicoptical uncertainty will be somewhat lower if determined on samples having higher activities or on samples run for a longer period of time. The electronic-optical uncertainty is not a constant but is a function of the transmittance.
Storage and Handling of Sample
As shown in the data from Table 1, precision decreases substantially in day-to-day interdisk analysis. We believe the uncertainty caused by changes in the sample that are secondary to storage, handling, and reactivation upon standing should be considered. The effect of this factor is very evident when the day-to-day coefficient of variation is compared with the intra-day coefficient of variation. We have noted, as have others (9), that the activity of the serum sample increases after thawing and standing at room temperature.
Assaying samples at various times during one day and on different days would result in disparate results. We believe that the high day-to-day variation in AP assays may not reflect the imprecision in the analyzer but a peculiarity of the particular enzyme system studied. The reason for the reactivation of AP over time has yet to be found. The values for the individual isoenzymes in serum samples are computed from the information summarized in Table 4 . For our calculations all of the L-phenylalanine-sensitive isoenzymes are assumed to come from intestinal sources. In the case of increased L-phenylalanine -sensitive AP activity, other tests are indicated to exclude as its source a tumor or placenta.
The branching logic used to compute the activity of the main isoenzymes present in serum samples is illustrated in Figure 3 . Three determinations are made on the centrifugal analyzer: (a) total AP activity; (b) AP activity with lO-millimolar L-phenylalanine; and (c) AP activity with 3.3 molar urea. Those values are labeled in Figure 3 as "T", "P", and "U", respectively.
The intestinal fraction is determined first and then subtracted from the total (T) and ureainsensitive (U) AP activity. The new values for total and urea-insensitive AP activity minus intestinal fractions are labeled "T" and "U" and are, in turn, used to determine the bone and liver fractions.
Normal Values
The results of total AP activity and quantitative isoenzyme determinations on 91 normal volunteers are presented in Table 5 . The volunteers were divided into three groups based on age. The activities of the "liver" and "intestinal" AP fractions were independent of the subject's age. In Figure 4 we demonstrate the threefold difference in total AP activity in the two younger groups as compared to the adults. The differences in total AP among the various groups were related mainly to the bone isoenzyme. Fig. 3 . Flow diagram of computer program used to compute AP isoenzyme fractions The variation in "bone" AP was greatest in the second group (ages 13 through 17 years), with females having lower values than males in the same age group. About half the samples from groups I and II and about a third from group ifi had no intestinal fraction present. The absolute value of the "intestinal" AP, when present, was independent of the subject's age and never exceeded 22% of the total AP. Results for the three age-dependent groups are graphically compared in Figure 4 . lsoenzyme Determinations in Diseased States Table 6 presents a number of values from patients with increased AP values. In each case the values for the isoenzyme were consistent with the clinical history. In all cases of suspected osteoblastic activity, the "bone" fraction was the predominant fraction. In the case of suspected liver disease, the "liver" fraction was the major contributor to the total AP. In none of our patients has the intestinal component been dominant.
Eight patients with carcinoma of the lung were also tested for tumor (Regan) isoenzyme; however, in each instance negligible activity remained after the serum was heated at 65#{176}C for 5 mm before running the sample in the assay mixture, indicating that this isoenzyme did not contribute to the total activity (11).
Discussion
Measurement of alkaline phosphatase activity by an advanced centrifugal analyzer appears to be precise and accurate. The instrumental error, as determined in the conditions of our assay system, contributed an electronic-optical uncertainty of 0.34%. This value, of course, only reflects the conditions under which the test was run. The variation in pipetting the serum volume is as significant as the instrumental error when a very precise system was used, but is much greater when conventional pipets are used. The availability of the small computer in the Aminco ROTOCHEM centrifugal analyzer allowed us to manipulate the data, to determine enzyme rates at various selected timed intervals. Our assay system conforms to the suggestions of McComb and Bowers (12) in our use of p-nitrophenylphosphate as substrate and diethanolamine buffer. The significant day-to-day variation in results on the same pooled sample may possibly be attributed to reactivation of the sera after thawing and standing at room temperature during the day. This increase in AP activity was first noted by Bodansky et al. (13) , and has been confirmed recently by others (9, 14) . Unless "time-corrections" are made for this source of error, the reactivation changes in AP activity will remain the limiting factor in the precision of future AP determinations.
The AP isoenzyme was measured by using L-phenylalanine and urea as selective chemical inhibitors of the organ-specific isoenzymes. Fishman and Ghosh (15) have noted that intestinal, placental, and tumor AP are greatly inhibited by L-phenylalanine, whereas bone and liver AP are not so affected. The effect of urea on .organ-specific AP isoenzymes has been extensively studied by Birkitt et al. (16) . Urea inhibits bone AP more than it does liver AP.
Heat and urea are similar in their ability to inhibit bone AP to a greater extent than the liver isoenzyme. However, the temperature for heat inhibition must be controlled very precisely, as repetitive results may vary as much as 50% with one degree variation from 56#{176}C (17) . Because of this, we elected to use a concentrated solution of urea rather than heat as a selective inhibitor of bone AP. Winkleman et al. (18) were unable to distinguish the "bone" and "liver" AP isoenzyme by using urea; however, they used a relatively dilute urea solution. The more concentrated solutions of urea that we used also enabled us to decrease the preincubation time required by others (19) . The flexibility of the centrifugal analyzer permitted us to select a predetermined timed interval for which to compute the total AP activity. The concentration of the urea in the incubation mixture and in the assay mixture was unchanged.
These advantages, as well as the increased precision of the centrifugal analyzer, decreased the spread of values of residual AP remaining after exposure to urea that has been noted by previous workers.
Electrophoresis as a means of separating and identifying isoenzymes of AP is generally considered to be laborious and time-consuming.
Moreover, the results are often difficult to interpret because of the overlap of the bone and liver isoenzyme (20) . The use of electrophoresis in combination with heat and (or) urea has recently been advocated (21) . Selective chemical inhibition as a means of distinguishing AP isoenzymes has the advantages of giving quantitative results as well as being very easy to perform, taking no longer than the time necessary to determine total AP activity.
In our group of normal volunteers, the predominant AP isoenzyme found in sera originated from bone. The question of the relative contributions of bone AP and liver AP to the normal total adult serum AP is still unresolved.
Both electrophoretic (22) and immunologic (23) studies suggest that the isoenzyme from liver is the major one in normal adult serum. However, heat and urea stability studies (17) indicate either equal contributions from bone AP and liver AP or even a predominance of bone AP. Our results are consistent with the latter view. The difference between the pediatric and adult population in total AP activity can be attributed to differences in the activity of this isoenzyme. In all the patients that we have studied, the activity of the different isoenzymes has correlated well with the clinical state.
